ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 893

Epidemiological Features of Childhood IgA Vasculitis (Henoch-Schönlein) in a French County: A Population-Based Survey

Maryam Piram1, Carla Maldini2, Sandra Biscardi3, Nathalie De Suremain4, Christine Orzechowski5, Emilie Georget6, Delphine Regnard7, Isabelle Koné-Paut1 and Alfred Mahr2, 1Pediatric Rheumatology, CHU Bicêtre, Le Kremlin Bicêtre, France, 2Internal Medicine, Hospital Saint-Louis, Paris, France, 3Pediatrics, Centre Hospitalier Intercommunal Créteil, Créteil, France, 4Pediatrics, CHU Trousseau, Paris, France, 5Pediatrics, CH Sainte Camille, Bry-sur-Marne, France, 6Pediatrics, Centre hospitalier de Villeneuve-Saint-Georges, Villeneuve Saint Georges, France, 7Pediatrics, CHU Bicêtre, Le Kremlin Bicêtre, France

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: epidemiologic methods and population studies, Henoch-Schönlein purpura

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 8, 2015

Title: Vasculitis Poster I

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose: IgA vasculitis (IgAV, Henoch–Schönlein) is the most common childhood vasculitis in western countries. Population-based studies mainly carried out in Europe over the last 4 decades reported annual incidence rates of 3 to 27 per 100,000 children. The etiology of IgAV remains unclear. Incidence peaks in the colder months suggested an infectious underpinning, although genetic susceptibility and other environmental triggers might also play a role. More epidemiological studies are required to determine potential changes over time in the epidemiological characteristics of IgAV. This study aimed at describing the epidemiological characteristics of childhood IgAV in a large French population.

Methods: Cases were prospectively collected in Val de Marne county, a southeastern suburb of Paris, with 262,124 residents < 15 years old. Children with incident IgAV living in this area from 2012 to 2014 were identified by 4 sources of case notification (emergency departments, pediatrics departments, private practice pediatricians, general practitioners). Diagnoses were verified against the EULAR/PRINTO/PRES criteria. We calculated 95% confidence intervals (95% CIs) for incidence rates under the assumption of a Poisson distribution. Four-source capture–recapture analysis (CRA) was performed using log-linear modeling to estimate the completeness of case finding. Seasonal variations in IgAV incidence were investigated by comparing observed to expected frequencies by chi-square testing.

Results: The survey identified 151 incident cases meeting the study criteria, including 79 (52%) boys and 72 (48%) girls with a mean age of 6.7 years (standard deviation: 2.7 years; range 2.2–15.7 years). The overall annual incidence (per 100,000 children) was 19.2 (95% CI: 16.2–22.4), with 19.7 (95% CI: 15.6–24.5) for boys and 18.7 (95% CI: 14.6–23.5) for girls. CRA estimated the completeness of case finding at 61.9% (95% CI: 50.0–81.2). The annual distribution of diagnoses (spring: 29%, summer: 12%, fall: 26%, winter: 33%) significantly deviated from a random distribution (P<0.01) and indicated a higher incidence in fall or winter as compared with spring or summer (P<0.01). Clinical manifestations at presentation included purpura (100%), urticaria (12%), arthralgias/arthritis (93%), acral edema (72%), abdominal involvement (59%), scrotal edema (13%) and renal involvement (21%). Abdominal manifestations included pain (55%), vomiting (26%), diarrhea (13%), hemorrhage (7%) and intussusception (2%). Renal involvement was mostly mild and diagnosed from findings of proteinuria and hematuria; only 3 children (2%) underwent renal biopsy.

Conclusion: The annual incidence rate of 19.2 per 100,000 children, gender distribution and seasonal variation we observed are in line with data reported from other geographic areas and time periods. In contrast, the small proportion and mild presentation of IgAV-associated renal disease supports the rather benign profile of IgAV at the population level.


Disclosure: M. Piram, None; C. Maldini, None; S. Biscardi, None; N. De Suremain, None; C. Orzechowski, None; E. Georget, None; D. Regnard, None; I. Koné-Paut, None; A. Mahr, None.

To cite this abstract in AMA style:

Piram M, Maldini C, Biscardi S, De Suremain N, Orzechowski C, Georget E, Regnard D, Koné-Paut I, Mahr A. Epidemiological Features of Childhood IgA Vasculitis (Henoch-Schönlein) in a French County: A Population-Based Survey [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/epidemiological-features-of-childhood-iga-vasculitis-henoch-schonlein-in-a-french-county-a-population-based-survey/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/epidemiological-features-of-childhood-iga-vasculitis-henoch-schonlein-in-a-french-county-a-population-based-survey/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology